Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009:3:175-82.
doi: 10.2147/opth.s3926. Epub 2009 Jun 2.

Treatment of neovascular age-related macular degeneration: Current therapies

Albert J Augustin  1 , Stefan Scholl, Janna Kirchhof
Affiliations

Treatment of neovascular age-related macular degeneration: Current therapies

Albert J Augustin et al. Clin Ophthalmol. 2009.

Abstract

Choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD) is now the leading cause of blindness and severe vision loss among people over the age of 40 in the Western world. Its prevalence is certain to increase substantially as the population ages. Treatments currently available for the disease include laser photocoagulation, verteporfin photodynamic therapy, and intravitreal injections of corticosteroids and anti-angiogenic agents. Many studies have reported the benefits of each of these treatments, although none is without its risks. No intervention actually cures AMD, nor the neovascularization associated with it. However, its symptoms are treated with varying degrees of success. Some treatments stabilize or arrest the progress of the disease. Others have been shown to reverse some of the damage that has already been done. These treatments can even lead to visual improvement. This paper will review the major classes of drugs and therapies designed to treat this condition.

Keywords: PDT; anti-angiogenesis; neovascularization; steroids; wet AMD.

PubMed Disclaimer

References

    1. Haab O. Erkrankungen der macula Lutea. Zentralbl Augenheilkd. 1885;9:384–391.
    1. Nettleship E. Central areolar choroidal atrophy. Trans Ophthalmol Soc U K. 1884;4:165–166.
    1. Leibowitz HM, Krueger DA, Maunder RA, et al. The Framingham Eye Study monograph; an ophthalmological study of cataract, glaucoma, diabetic retinopathy, macular degeneration and visual acuity in a general population of 2631 adults 1973–75. Surv Ophthalmol. 1980;24(Suppl):335–610. - PubMed
    1. Friedman DS, O’Colmain BJ, Muñoz B, et al. Eye Diseases Prevalence Research Group Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122:564–572. - PubMed
    1. Congdon N, O’Colmain B, Klaver CC, the Eye Diseases Prevalence Research Group Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122:477–485. - PubMed